A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia With High Platelet Desialylation Level
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Oseltamivir (Primary) ; Dexamethasone
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 18 Apr 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2017.
- 18 Apr 2016 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2017.
- 18 Apr 2016 Planned initiation date changed to 1 Oct 2016.